Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Phys Rev Lett ; 92(15): 157001, 2004 Apr 16.
Artigo em Inglês | MEDLINE | ID: mdl-15169307

RESUMO

The novel vortex phase and nature of the double transition field are investigated by two-component Ginzburg-Landau theory in a situation where fourfold-twofold symmetric superconducting double transition occurs. The deformation from 60 degrees triangular vortex lattice and a possibility of the vortex sheet structure are discussed. In the presence of the gradient coupling, the transition changes to a crossover at finite field. These characters are important to identify the multiple superconducting phase in PrOs4Sb12.

2.
Pharm Res ; 20(6): 848-56, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12817887

RESUMO

PURPOSE: To evaluate the potential of phosphate ester prodrugs to significantly improve the absorptive flux of poorly soluble parent drugs. METHODS: Absorptive transport studies of parent drugs and their prodrugs were carried out in Caco-2 cells. Prodrugs of parent drugs with variable aqueous solubilities were tested: Hydrocortisone-phosphate/Hydrocortisone, Fosphenytoin/phenytoin, TAT-59/DP-TAT-59, and Entacapone phosphate/Entacapone. Additional absorption studies were carried out in rats. RESULTS: Absorptive fluxes of DP-TAT-59 and phenytoin increased 9.8 or 3.3-fold after dosing TAT-59 and 500 microM fosphenytoin, respectively. Hydrocortisone's flux did not increase with hydrocortisone-phosphate at 100 microM. Permeability of the highly lipophilic and protein bound compound, DP-TAT-59, was significantly increased with serosal albumin. No permeability increase was observed for the other drugs with albumin. Entacapone phosphate failed to improve the flux of entacapone compared to an entacapone solution, but the prodrug solution did yield higher entacapone plasma levels in rats when compared with an entacapone suspension. CONCLUSION: Ideal phosphate prodrug candidates are characterized by high permeability and low solubility (BCS Class II drugs). For low dose BCS Class II drug candidates, however, no biopharmaceutical advantage may be gained. Phosphate prodrugs of parent drugs with limited permeability may fail. When screening highly lipophilic parent drugs transport studies should be done with albumin.


Assuntos
Absorção Intestinal/fisiologia , Fenitoína/análogos & derivados , Pró-Fármacos/farmacocinética , Tamoxifeno/análogos & derivados , Administração Oral , Algoritmos , Animais , Área Sob a Curva , Transporte Biológico Ativo , Células CACO-2 , Catecóis/farmacocinética , Fenômenos Químicos , Físico-Química , Humanos , Hidrocortisona/farmacocinética , Concentração de Íons de Hidrogênio , Técnicas In Vitro , Mucosa Intestinal/metabolismo , Jejuno/metabolismo , Masculino , Nitrilas , Perfusão , Permeabilidade , Fenitoína/química , Fenitoína/farmacocinética , Ratos , Ratos Wistar , Tamoxifeno/química , Tamoxifeno/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...